Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
5.06
+0.13 (2.64%)
Mar 6, 2026, 4:00 PM EST - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $187.40 million as of March 6, 2026. Its market cap has increased by 0.60% in one year.
Market Cap
187.40M
Enterprise Value
55.08M
1-Year Change
0.60%
Ranking
Category
Stock Price
$5.06
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $187.40M, a decrease of -68.53%. That is a compound annual growth rate of -13.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 191.81M |
| Compugen | 187.07M |
| Tiziana Life Sciences | 186.33M |
| SAB Biotherapeutics | 185.19M |
| Sagimet Biosciences | 182.77M |
| Canton Strategic Holdings | 182.63M |
| Nkarta | 182.55M |
| NeOnc Technologies Holdings | 178.77M |